The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

For infectious-disease outbreaks, clinical solutions typically focus on efficient pathogen
destruction. However, the COVID-19 pandemic provides a reminder that infectious diseases …

Background With evidence of sustained transmission in more than 190 countries,
coronavirus disease 2019 (COVID-19) has been declared a global pandemic. Data are …

ACE2 is the indispensable entry receptor for SARS-CoV and SARS-CoV-2. Because of the
COVID-19 pandemic, it has become one of the most therapeutically targeted human …

A novel coronavirus disease, COVID-19, has created a global pandemic in 2020, posing an
enormous challenge to healthcare systems and affected communities. COVID-19 is caused …

The angiotensin-converting enzyme 2 (ACE2) is the host functional receptor for the new
virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different …

Background The novel severe acute respiratory syndrome coronavirus (SARS‐CoV‐2)
disease 2019 (COVID‐19) seems to have a worse clinical course among infected men …

Covid-19 is a recently-emerged infectious disease caused by the novel severe acute
respiratory syndrome coronavirus SARS-CoV2. SARS-CoV2 differs from previous …

Background and aims Clinical evidence exists that patients with diabetes are at higher risk
for Coronavirus disease 2019 (COVID-19). We investigated the physiological origins of this …

In December 2019, a new and highly contagious infectious disease emerged in Wuhan,
China. The etiologic agent was identified as a novel coronavirus, now known as Severe …